Spaventa Andrew
Chief Executive Officer at OMIC
- Sold, on record
- $37k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 14, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- OMICSingular Genomics Systems, Inc.Chief Executive Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale OMICNo planSep 15, 2024 2024
Sold 175 shares at $12.38 ($2k)
Spaventa Andrew, Chief Executive Officer
No 10b5-1 planSold 21.6% of holdings ($10k position)637 shares leftFirst sale on recordFiling
- 2 Form 4 sale OMICUnusualNov 12, 2024 +58 days
Sold 695 shares at $22.55 ($16k)
Spaventa Andrew, Chief Executive Officer
No 10b5-1 planSold 31.1% of holdings ($50k position)1,537 shares leftFiling
- 3 Form 4 sale OMICNo planDec 16, 2024 +34 days
Sold 180 shares at $20.16 ($4k)
Spaventa Andrew, Chief Executive Officer
No 10b5-1 planSold 22.2% of holdings ($16k position)631 shares leftFiling
- 4 Form 4 sale OMICUnusualFeb 14, 2025 +60 days
Sold 800 shares at $19.89 ($16k)
Spaventa Andrew, Chief Executive Officer
No 10b5-1 planSold 35.8% of holdings ($44k position)1,432 shares left4.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Feb 14, 2025 | OMIC | Chief Executive Officer | Form 4 sale | 800 | $16k | 35.8% | Unusual | SEC |
| Dec 16, 2024 | Dec 17, 2024 | OMIC | Chief Executive Officer | Form 4 sale | 180 | $4k | 22.2% | No plan | SEC |
| Nov 12, 2024 | Nov 13, 2024 | OMIC | Chief Executive Officer | Form 4 sale | 695 | $16k | 31.1% | Unusual | SEC |
| Sep 15, 2024 | Sep 17, 2024 | OMIC | Chief Executive Officer | Form 4 sale | 175 | $2k | 21.6% | No plan | SEC |